Related Experiment Video
Updated: May 6, 2026
12:17
Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.
Published on: March 17, 2008
15.1K
Industry Update: The latest developments in therapeutic delivery.
1Tower Pharma Consulting, Auhofstrasse 197/10, Vienna, 1130, Austria. louise.templeton@towerpharmacon.com.
Therapeutic Delivery
|November 16, 2013
Summary
Amgen acquired Onyx Pharmaceuticals for $10.4 billion. The European Medicines Agency released guidance on nanomedicine development and quality control for nanomedicines and nanosimilars.
Area of Science:
- Pharmaceutical Sciences
- Biotechnology
- Regulatory Science
Background:
- Industry news in therapeutic delivery from August 2013.
- Key events include a major acquisition and regulatory guidance publication.
Purpose of the Study:
- To summarize significant developments in therapeutic delivery during August 2013.
- To highlight the Amgen-Onyx acquisition and EMA's nanomedicine reflection paper.
Main Methods:
- Review of press releases and company websites.
- Analysis of major industry news and regulatory publications.
Main Results:
- Amgen's $10.4 billion acquisition of Onyx Pharmaceuticals, a significant event in the biotechnology sector.
- Publication of a European Medicines Agency reflection paper on nanomedicine coating, quality control, and assurance for nanomedicines and nanosimilars.
Conclusions:
- The therapeutic delivery landscape in August 2013 was marked by substantial M&A activity and evolving regulatory considerations for advanced drug delivery systems.
Related Concept Videos
01:16Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
01:19Modified-Release Drug Delivery Systems: Overview
243
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
243
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165
01:22Drug Delivery: Miscellaneous Routes
1.2K
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
1.2K
01:27Drug Delivery Systems: Different Types
418
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
418
01:20Modified-Release Drug Delivery Systems: Influencing Factors
215
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
215